Cytokine Inhibitors and Graft‐versus‐Host Disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (38)
Cytokine dysregulation and acute graft-versus-host disease
1992 • 617 citations
Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
1987 • 609 citations
Cytokine dysregulation and acute graft-versus-host disease
1992 • 565 citations
Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide.
1991 • 448 citations
Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin.
1992 • 428 citations
Immunomodulatory and Antimicrobial Efficacy of Intravenous Immunoglobulin in Bone Marrow Transplantation
1990 • 398 citations
Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.
1992 • 385 citations
Risk factors for acute graft‐versus‐host disease
1987 • 360 citations
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
1993 • 233 citations
IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently.
1991 • 219 citations
Differential cytokine expression in acute and chronic murine graft‐versus‐host‐disease
1993 • 194 citations
Preferential activation of Th2 cells in chronic graft-versus-host reaction.
1993 • 187 citations
Enhancement of Growth of Virulent Strains of Escherichia coli by Interleukin-1
1991 • 185 citations
Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease
1991 • 180 citations
Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat.
1992 • 179 citations
Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction.
1989 • 178 citations
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
1992 • 176 citations
Host-Specific Interleukin-2–Secreting Donor T-Cell Precursors as Predictors of Acute Graft-versus-Host Disease in Bone Marrow Transplantation between HLA-Identical Siblings
1992 • 167 citations
Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease
1994 • 141 citations
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
1992 • 139 citations
Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation
1993 • 134 citations
Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice.
1993 • 129 citations
Dissociating graft-vs-host disease from the graft-vs-leukemia effect of allogeneic T cells: the potential role of IL-2.
1992 • 118 citations
ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATION
1990 • 110 citations
Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.
1993 • 106 citations
Nitric oxide mediates intestinal pathology in graft-vs.-host disease
1992 • 103 citations
In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.
1990 • 98 citations
THE RELATIONSHIP OF SERUM IL-6 LEVELS TO ACUTE GRAFT-VERSUS-HOST DISEASE AND HEPATORENAL DISEASE AFTER HUMAN BONE MARROW TRANSPLANTATION
1992 • 92 citations
Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model.
1991 • 82 citations
Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression.
1988 • 80 citations
Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR.
1992 • 59 citations
Cytokine gene expression in mice undergoing chronic graft-versus-host disease
1993 • 56 citations
Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease.
1991 • 51 citations
Effects of in vivo administration of interferon (IFN)-γ, anti-IFN-γ, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease
1992 • 42 citations
Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT.
1993 • 40 citations
Quantitative assessment of posttransplant host-specific interleukin-2- secreting T-helper cell precursors in patients with and without acute graft-versus-host disease after allogeneic HLA-identical sibling bone marrow transplantation
1993 • 32 citations
Cytokines in Hemopoiesis, Oncology, and AIDS II
1992 • 30 citations
SERUM LEVELS AND RECEPTOR EXPRESSION OF TUMOR NECROSIS FACTOR-α FOLLOWING HUMAN ALLOGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANTATION
1992 • 16 citations